Lv Bin, Gan Weikang, Cheng Zhangrong, Wu Juntao, Chen Yuhang, Zhao Kangchen, Zhang Yukun
Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Pharmacol. 2022 Jun 8;13:842525. doi: 10.3389/fphar.2022.842525. eCollection 2022.
Intervertebral disc degeneration (IDD), characterized by conversion of genotypic and phenotypic, is a major etiology of low back pain and disability. In general, this process starts with alteration of metabolic homeostasis leading to ongoing inflammatory process, extracellular matrix degradation and fibrosis, diminished tissue hydration, and impaired structural and mechanical functionality. During the past decades, extensive studies have focused on elucidating the molecular mechanisms of degeneration and shed light on the protective roles of various factors that may have the ability to halt and even reverse the IDD. Mutations of GDF-5 are associated with several human and animal diseases that are characterized by skeletal deformity such as short digits and short limbs. Growth and differentiation factor-5 (GDF-5) has been shown to be a promise biological therapy for IDD. Substantial literature has revealed that GDF-5 can decelerate the progression of IDD on the molecular, cellular, and organ level by altering prolonged imbalance between anabolism and catabolism. GDF family members are the central signaling moleculars in homeostasis of IVD and upregulation of their gene promotes the expression of healthy nucleus pulposus (NP) cell marker genes. In addition, GDF signaling is able to induce mesenchymal stem cells (MSCs) to differentiate into NPCs and mobilize resident cell populations as chemotactic signals. This review will discuss the promising critical role of GDF-5 in maintenance of structure and function of IVDs, and its therapeutic role in IDD endogenous repair.
椎间盘退变(IDD)以基因型和表型的转变为特征,是下腰痛和残疾的主要病因。一般来说,这个过程始于代谢稳态的改变,导致持续的炎症过程、细胞外基质降解和纤维化、组织水合作用减弱以及结构和机械功能受损。在过去几十年中,广泛的研究集中在阐明退变的分子机制,并揭示各种可能有能力阻止甚至逆转IDD的因素的保护作用。生长分化因子5(GDF-5)的突变与几种以骨骼畸形为特征的人类和动物疾病相关,如短指和短肢。生长分化因子5(GDF-5)已被证明是一种有前景的IDD生物治疗方法。大量文献表明,GDF-5可以通过改变合成代谢和分解代谢之间长期的失衡,在分子、细胞和器官水平上减缓IDD的进展。GDF家族成员是椎间盘稳态的核心信号分子,其基因的上调促进健康髓核(NP)细胞标记基因的表达。此外,GDF信号能够诱导间充质干细胞(MSCs)分化为NPCs,并作为趋化信号动员驻留细胞群体。本综述将讨论GDF-5在维持椎间盘结构和功能方面的关键作用及其在IDD内源性修复中的治疗作用。